Cargando…
LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage
In the United States, 5–12% of adults have at least one symptom of temporomandibular joint (TMJ) disorders, including TMJ osteoarthritis (TMJ-OA). However, there is no chondroprotective agent that is approved for clinical application. We showed that LOXL2 is elevated in the regenerative response dur...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678826/ https://www.ncbi.nlm.nih.gov/pubmed/33214607 http://dx.doi.org/10.1038/s41598-020-77178-9 |